BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 25881932)

  • 1. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.
    Cheng ML; Wang CH; Shiao MS; Liu MH; Huang YY; Huang CY; Mao CT; Lin JF; Ho HY; Yang NI
    J Am Coll Cardiol; 2015 Apr; 65(15):1509-20. PubMed ID: 25881932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified plasma essential amino acid-based profiling provides metabolic information and prognostic value additive to traditional risk factors in heart failure.
    Wang CH; Cheng ML; Liu MH
    Amino Acids; 2018 Dec; 50(12):1739-1748. PubMed ID: 30203393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino Acid-Based Metabolic Panel Provides Robust Prognostic Value Additive to B-Natriuretic Peptide and Traditional Risk Factors in Heart Failure.
    Wang CH; Cheng ML; Liu MH
    Dis Markers; 2018; 2018():3784589. PubMed ID: 30405858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
    Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels.
    Daniels LB; Clopton P; Jiang K; Greenberg B; Maisel AS
    J Card Fail; 2010 Feb; 16(2):93-8. PubMed ID: 20142019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
    Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M
    J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure.
    Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
    J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Metabolomics Reveals Heart Failure With Midrange Ejection Fraction as a Distinct Phenotype of Heart Failure.
    Zhao H; Shui B; Zhao Q; Hu Z; Shu Q; Su M; Zhang Y; Ni Y
    Can J Cardiol; 2021 Feb; 37(2):300-309. PubMed ID: 32795449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events.
    Dhaliwal AS; Deswal A; Pritchett A; Aguilar D; Kar B; Souchek J; Bozkurt B
    J Card Fail; 2009 May; 15(4):293-9. PubMed ID: 19398076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.